ARWR
Arrowhead Pharmaceuticals Inc
61.50$
-1.3%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.0% | 0.1% | -95.2% | -321.9% | -878.6% | -4,670.4% | – | -1,179.0% | -1,540.5% | -2,484.0% | -1,975.7% | -2,116.7% | -406.5% | -1,241.6% | -1,820.3% | -10,444.5% | -6,557.2% | -20,237.9% | -17,200.9% | -40,691.1% | -76.2% | -292.5% | 102.5% | -108.9% | 123.9% | -56.0% | -63.9% | -13,034.4% | 21.6% | |
| 135.5% | 15.2% | 21.9% | 30.6% | 37.9% | 400.6% | – | 38.1% | 109.0% | 149.0% | 83.1% | 87.0% | 26.5% | 44.8% | 90.5% | 1,190.8% | 603.4% | 768.9% | 611.6% | 2,059.0% | 14.9% | 29.1% | 2.6% | 6.8% | 6.0% | 4.3% | 5.2% | 523.7% | 2.9% | |
| – | – | – | – | – | – | – | 72.6% | – | 229,987.3% | – | – | 71.2% | 229.7% | 465.0% | 845.2% | 529.3% | 3,255.0% | 2,678.8% | 7,323.7% | 25.1% | 52.4% | 7.3% | 49.3% | 55.4% | 49.7% | 32.5% | 2,083.0% | 7.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,056.0% | 1,519.6% | 2,381.5% | 8,045.5% | 5,073.0% | 5,106.4% | 22.3% | 49.7% | 8.0% | 49.3% | 55.4% | 51.5% | 37.6% | – | – | |
| 115.0% | 254.2% | 173.6% | 197.1% | 1,633.3% | 8,069.3% | – | 20.9% | 75.3% | 227.6% | 3.4% | -17.9% | -21.9% | -145.4% | 2.3% | 147.1% | 48.2% | 2,859.8% | 892.1% | 3,611.6% | -3.8% | -36.4% | 51.6% | -69.4% | 165.4% | -40.4% | -21.4% | 706.6% | -2.2% | |
| 0.0% | 0.0% | 0.0% | 3.0% | 0.0% | 73.9% | – | 339.0% | 113.9% | 156.9% | 62.6% | 52.5% | 1.1% | 0.9% | 3.3% | 326.6% | 102.3% | 981.3% | 515.9% | 2,438.0% | 25.2% | 8.8% | 7.1% | 13.6% | 17.0% | 21.7% | 73.4% | 3,983.9% | 2.7% | |
| – | – | – | -3.0% | – | -73.9% | – | -183.2% | 384.2% | -91.0% | 362.6% | -197.6% | 19.7% | 78.6% | -59.2% | 300.0% | -3,280.0% | -20,846.7% | 3,696.6% | 8,493.3% | -154.9% | -46.1% | -28.3% | -273.6% | -102.5% | -2.2% | -39.9% | -11,829.7% | -15.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,522.1% | 7,460.9% | 15,332.8% | 106,011.3% | 132.1% | -400.5% | -1.4% | -0.3% | 40.8% | 293.1% | 8.2% | 2.1% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -133.9% | -74.0% | -128.8% | -56.0% | -137.4% | -0.6% | -1.3% | -1.4% | 284.1% | 180.8% | 102.8% | 103.8% | 11,039.1% | -23.1% | |
| -5.8% | -0.3% | 92.8% | 332.2% | 860.5% | 5,548.4% | – | 5,028.6% | 3,511.9% | 3,507.6% | 1,290.3% | 1,237.9% | 172.0% | 1,941.4% | 2,102.5% | 7,332.5% | 15,258.8% | 105,882.5% | 76.1% | 34,820.2% | 38.4% | 371.4% | 39.3% | 293.1% | 8.2% | 26.8% | 105.1% | 24,514.8% | 8.9% | |
| 0.2% | -0.2% | -2.4% | 7.3% | -18.1% | 804.1% | – | 3,666.4% | 2,355.6% | 932.6% | -322.9% | -1,076.3% | -214.8% | 778.4% | 222.9% | -2,812.0% | 5,421.6% | 64,797.8% | -13,428.3% | 2,622.4% | -192.7% | 32.8% | 113.6% | -88.9% | 29.5% | -31.4% | 1.2% | -231.1% | 14.9% | |
| 6.0% | 0.1% | -95.2% | -324.9% | -878.6% | -4,744.3% | – | -1,518.0% | -1,654.4% | -2,640.9% | -2,038.3% | -2,169.2% | -407.6% | -1,241.6% | -1,823.6% | -10,771.1% | -6,659.4% | -21,219.3% | -17,716.8% | -43,129.2% | -101.4% | -301.3% | 95.4% | -122.5% | 106.8% | -77.7% | -137.3% | -17,018.3% | 18.9% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.